SCHEMBL23959493

SCHEMBL23959493

CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc2c(c1)c1cc(-n3c4ccc(C(C)(C)C)cc4c4cc(C(C)(C)C)ccc43)ccc1n2-c1ccc(-c2cnc3nc(-c4ccccc4)c(-c4ccccc4)n3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 8/20 0.48
▸ AKT2 P31751 8/20 0.48
▸ ROCK2 O75116 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ MDM2 Q00987 1/20 0.33
▸ MGAM O43451 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ SI P14410 1/20 0.32
▸ MGAM2 Q2M2H8 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ PIK3C2A O00443 1/20 0.31
▸ PIK3C2B O00750 1/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ ABCB11 O95342 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ MET P08581 1/20 0.31
▸ PIK3R1 P27986 1/20 0.31
▸ LTK P29376 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959215 0.98 AKT1 (0.49) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959231 0.91 AKT1 (0.40) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959240 0.90 AKT1 (0.53) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959492 0.89 AKT1 (0.52) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959228 0.88 AKT1 (0.41) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959491 0.88 AKT1 (0.54) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959209 0.86 AKT1 (0.51) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959197 0.85 AKT1 (0.42) AKT1AKT2
SCHEMBL23959244 0.84 AKT1 (0.51) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959207 0.83 AKT1 (0.56) AKT1AKT2ROCK2PIM1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback